MANSC (415-431) (Human) [4993]



MANSC (415-431) (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)O
InChIKey CCMVMLBWJFAFRO-IAMXVIFYSA-N
Sequence KRYSRLDYLINGIYVDI
HELM PEPTIDE1{K.R.Y.S.R.L.D.Y.L.I.N.G.I.Y.V.D.I}$$$$

Chemical Properties

Hydrogen bond acceptors 28
Hydrogen bond donors 30
Rotatable bonds 69
Log P -5.429
Molecular weight (Da) 2100.1
Stereochemistry info partial

Database connections

Model (AF2) GPR55


No bioactivity data available.

MANSC (415-431) (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) GPR55


Compound is not listed as a drug.